Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2013 /
The immune microenvironment as an anti-cancer therapeutic strategy

3rd - 6th Nov 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.11.13
Views: 3205

Dr Lisa Coussens - Oregon Science & Health University, USA

Dr Lisa Coussens talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about inflammation and cancer and how this can be used in the tumour microenvironment.

By studying transgenic mouse models of skin, lung, breast and pancreas cancer development, Dr Coussens lab found that adaptive leukocytes differentially regulate myeloid cell recruitment, activation, and behaviour, by organ-dependent mechanisms.

This has been translated into a recent clinical trial involving triple negative breast cancer.

Read the conference report of the NCRI 2013 meeting for free.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation